Agile Thrpe is a drug manufacturers - specialty & generic business based in the US. Agile Thrpe shares (AGRX) are listed on the NASDAQ and all prices are listed in US Dollars. Agile Thrpe employs 19 staff and has a trailing 12-month revenue of around $21.5 million.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $1.44 |
|---|---|
| 52-week range | $0.20 - $3.03 |
| 50-day moving average | $0.75 |
| 200-day moving average | $1.17 |
| Wall St. target price | $5.00 |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $-0.52 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $1.44 from 2024-07-25
| 1 week (2024-07-19) | 0.70% |
|---|---|
| 1 month (2024-06-27) | 0.70% |
| 3 months (2024-04-26) | 260.00% |
| 6 months (2024-01-26) | -8.86% |
| 1 year (2023-07-27) | -45.14% |
|---|---|
| 2 years (2022-07-27) | 177.99% |
| 3 years (2021-07-27) | 29.73% |
| 5 years (2019-07-26) | 10.77% |
| Revenue TTM | $21.5 million |
|---|---|
| Gross profit TTM | $-6,617,000 |
| Return on assets TTM | -75.71% |
| Return on equity TTM | -1364.04% |
| Profit margin | -36.24% |
| Book value | $-1.51 |
| Market Capitalization | $9.8 million |
TTM: trailing 12 months
We're not expecting Agile Thrpe to pay a dividend over the next 12 months.
Agile Thrpe's shares were split on a 1:50 basis on 10 April 2023. So if you had owned 50 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Agile Thrpe shares – just the quantity. However, indirectly, the new 4900% higher share price could have impacted the market appetite for Agile Thrpe shares which in turn could have impacted Agile Thrpe's share price.
Over the last 12 months, Agile Thrpe's shares have ranged in value from as little as $0.2 up to $3.0314. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Agile Thrpe's is 1.582. This would suggest that Agile Thrpe's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Agile Therapeutics, Inc. , a women's healthcare company, engages in the research, development, and commercialization of prescription contraceptive products for women in the United States. It offers Twirla, a once-weekly prescription combination hormonal contraceptive patch. The company is also developing a pipeline of Twirla line extensions and other products, including AG200-15 Extended Regimen (ER), a regimen that allows a woman to have four episodes of withdrawal bleeding per year; AG200-15 smaller patch (SmP), which is a regimen designed to provide shorter and lighter withdrawal bleeds, and enhance contraceptive efficacy; AG200-15 ER SmP, a regimen to allow a woman to extend the length of her contraceptive cycle, as well as have shorter and lighter withdrawal bleeding episodes per year; and P-Patch, a progestin-only contraceptive patch intended for use by women who are unable or unwilling to take estrogen. Agile Therapeutics, Inc. was incorporated in 1997 and is headquartered in Princeton, New Jersey. .
Trade commission-free stocks and ETFs with Opto, and stay ahead by spotting emerging trends through thematic investing.
Check out our picks of the best paper trading platforms to practice trading and investing with fake money.
Learn the basics of put options: what they are, how they work and a few examples.
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
These are the best day trading platforms, according to Finder’s comprehensive analysis.
Explore the best bonuses for opening a new brokerage account.
Looking for a discount broker like Webull that offers something different? Here are some of the top alternatives to consider.
What you need to know about investing in the leading indicator for the overall US stock market.
Check out our 7 ideas for how to invest $10K to maximize your money.
Check out the best-performing ETFs so far in 2024.